Global Liquid Biopsy Markets 2015-2020: Market Size, Strategies and Forecasts 2015 to 2020 - Blood Tests Replace Surgical Biopsies To Create a New Multibillion Dollar Market Opportunity

Nov 19, 2015, 12:10 ET from Research and Markets

DUBLIN, Nov. 19, 2015 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Liquid Biopsy Markets: Global Market Size, Strategies and Forecasts 2015 to 2020 including Potential Market Sizing" report to their offering.

New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has outstanding growth potential. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening.

Use independent research that makes you the expert. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it.

Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers.

Key Topics Covered:

1. Introduction and Market Definition

2. Market Overview

3. Market Trends

4. Liquid Biopsy Recent Developments

5. Country Market Sizes - North America

6. Country Markets - Europe

7. Country Markets - Asia Pacific

8. Country Markets - Latin America, Africa & The Middle East

9. Global Market Summary

10. Potential Market Opportunity Sizes

Companies Mentioned

- AdnaGen (now Qiagen)
- Agena Bioscience
- Angle plc
- ApoCell
- Biocept
- BioFluidica
- Bio-Rad Laboratories
- Boreal Genomics
- Chronix Biomedical
- Clearbridge BioMedics
- Cynvenio
- Cytolumina Technologies Corp
- CytoTrack
- Diagnologix LLC
- Epic Sciences
- Exosome Diagnostics
- Exosome Sciences
- Fluidigm Corp
- Fluxion Biosciences
- Genomic Health
- Guardant Health
- HansaBiomed
- Horizon Discovery
- iCellate
- Illumina
- Inivata
- Janssen Diagnostics
- Molecular MD
- Myriad Genetics
- Natera
- New Oncology
- Personal Genome Diagnostics
- RainDance Technologies
- Rarecells SAS
- Silicon Biosystems
- SRI International
- Sysmex Inostics
- Trovagene

For more information visit

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood , +353-1-481-1716,

SOURCE Research and Markets